The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/39896
StudyName: Eligibility Human Epidermal Growth Factor 2 Negative Carcinoma of Breast NCT01885013
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 02.03.2020
License: Creative Commons BY 4.0

----

Description: 
Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01885013
